ABVC Biopharma Inc - ESG Rating & Company Profile powered by AI
This Disclosure score includes 17 United Nations Sustainable Development Goals including: 'Zero Hunger', 'Decent Work & Economic Growth' and 'Life on Land'. The analysis of ABVC Biopharma Inc employs intelligence from across the internet as well as from available disclosures by ABVC Biopharma Inc. This webpage of ABVC Biopharma Inc was prepared by All Street Sevva using proprietary NLP.
ABVC Biopharma Inc in the Commodity Chemicals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 0.0, social score of 8.0 and governance score of 2.0.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Calix Ltd | 8.0 | High |
| 1 | Castrol India Ltd | 8.0 | High |
| ... | ... | ... | |
| 391 | Supreme Industries Ltd | 3.4 | Medium |
| 391 | Toyo Gosei Co Ltd | 3.4 | Medium |
| 395 | ABVC Biopharma Inc | 3.3 | Medium |
| 396 | Kanchi Karpooram Ltd | 3.2 | Medium |
| 396 | Lake Area Corn Processors LLC | 3.2 | Medium |
| ... | ... | ... | |
| 591 | Zhejiang Zhongcheng Packing Material Co Ltd | 0.0 | Low |
| 591 | Zhuzhou Times New Material Technology Co Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does ABVC Biopharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes ABVC Biopharma Inc report the average age of the workforce?
Sign up for free to unlockDoes ABVC Biopharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes ABVC Biopharma Inc offer flexible work?
Sign up for free to unlockDoes ABVC Biopharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes ABVC Biopharma Inc conduct supply chain audits?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes ABVC Biopharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose water use targets?
Sign up for free to unlockDoes ABVC Biopharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid ABVC Biopharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes ABVC Biopharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas ABVC Biopharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes ABVC Biopharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes ABVC Biopharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs ABVC Biopharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose its waste policy?
Sign up for free to unlockDoes ABVC Biopharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose energy use targets?
Sign up for free to unlockDoes ABVC Biopharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes ABVC Biopharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for ABVC Biopharma Inc
These potential risks are based on the size, segment and geographies of the company.
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.